Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19470922 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
Condition: Leukemia
Intervention: Biological: Polyphenon E

Indicates status has not been verified in more than two years